Potential impact of PD- L1 (SP-142) immunohistochemical heterogeneity in clear cell renal cell carcinoma immunotherap

Jose I. Lopez, Rafael Pulido, Jesus M. Cortes , Javier C. Angulo, and Charles H. Lawrie. Potential impact of PD-L1 (SP-142) immunohistochemical heterogeneity in clear cell renal cell carcinoma immunotherapy.  Pathol Res Pract 2018 Aug;214(8):1110-1114. [pdf]

You may also like...